Sage Capital Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-80,355
Closed -$4.18M 109
2021
Q4
$4.18M Buy
80,355
+8,322
+12% +$408K 1.59% 23
2021
Q3
$3.56M Buy
72,033
+965
+1% +$52.4K 1.52% 27
2021
Q2
$4.17M Buy
71,068
+5,943
+9% +$347K 1.7% 21
2021
Q1
$3.96M Buy
65,125
+37
+0.1% +$2.04K 1.77% 23
2020
Q4
$3.64M Buy
65,088
+111
+0.2% +$5.76K 1.8% 19
2020
Q3
$3.05M Sell
64,977
-2,361
-4% -$121K 1.86% 19
2020
Q2
$3.51M Sell
67,338
-29
-0% -$1.5K 2.26% 12
2020
Q1
$3.23M Buy
67,367
+4,066
+6% +$211K 2.64% 9
2019
Q4
$3.2M Buy
63,301
+31,534
+99% +$1.63M 2.03% 16
2019
Q3
$1.5M Buy
31,767
+375
+1% +$17.1K 1.13% 33
2019
Q2
$1.42M Buy
+31,392
New +$1.45M 0.98% 36

Other funds holding CAH

Sage Capital Advisors's CAH Position: Q1 2022 in Review

Sage Capital Advisors sold out of Cardinal Health (CAH) in Q1 2022, closing a stake of 80,355 shares — an estimated $4.18M sold.

Sage Capital Advisors first reported a position in CAH in Q2 2019 and held it in 11 quarters. The position peaked at $4.18M in Q4 2021. 784 funds tracked by Wall St. Rank hold CAH as of Q1 2022.

  • Sage Capital Advisors reported no remaining Cardinal Health position as of Q1 2022 after selling out during the quarter.
  • Sage Capital Advisors sold 80,355 Cardinal Health shares in Q1 2022, an estimated $4.18M.
  • Sage Capital Advisors first reported a position in Cardinal Health in Q2 2019 and held it in 11 quarters.
  • Sage Capital Advisors's Cardinal Health position peaked at $4.18M in Q4 2021.
  • 784 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2022.

Based on Sage Capital Advisors's 13F filing for Q1 2022, filed 11 Apr 2022.